Insider Transactions in Q4 2024 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Christopher Van Tuyl Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,956
+50.0%
|
-
|
|
Dec 02
2024
|
Douglas J. Hughes Director |
SELL
Open market or private sale
|
Direct |
5,425
-4.34%
|
$151,900
$28.54 P/Share
|
|
Dec 02
2024
|
Atul Pande Director |
SELL
Open market or private sale
|
Direct |
7,750
-8.21%
|
$217,000
$28.54 P/Share
|
|
Nov 20
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,174
-1.24%
|
$104,350
$25.45 P/Share
|
|
Nov 20
2024
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,353
-0.92%
|
$83,825
$25.45 P/Share
|
|
Nov 20
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,650
-1.13%
|
$91,250
$25.45 P/Share
|
|
Nov 20
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,692
-1.68%
|
$417,300
$25.45 P/Share
|
|
Nov 18
2024
|
Melanie Gloria Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,956
+50.0%
|
-
|
|
Oct 23
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,361
-1.33%
|
$126,469
$29.53 P/Share
|
|
Oct 23
2024
|
Jay S Stout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,740
-1.89%
|
$79,460
$29.53 P/Share
|
|
Oct 23
2024
|
Michael Geffner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,189
-2.31%
|
$92,481
$29.53 P/Share
|
|
Oct 16
2024
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,188
-0.43%
|
$89,264
$28.79 P/Share
|
|
Oct 16
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,095
-0.91%
|
$254,660
$28.79 P/Share
|
|
Oct 16
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,271
-0.97%
|
$91,588
$28.79 P/Share
|
|
Oct 16
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,860
-0.87%
|
$80,080
$28.79 P/Share
|
|
Oct 09
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,460
-0.44%
|
$129,340
$29.56 P/Share
|
|
Oct 09
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,162
-1.5%
|
$149,698
$29.56 P/Share
|